lb-100
Showing 1 - 5 of 5
Metastatic Microsatellite-stable Colorectal Cancer Trial (LB-100, Atezolizumab)
Not yet recruiting
- Metastatic Microsatellite-stable Colorectal Cancer
- LB-100
- Atezolizumab
- (no location specified)
Sep 1, 2023
Metastatic Colorectal Cancer Trial (LB-100, Azenosertib)
Not yet recruiting
- Metastatic Colorectal Cancer
- LB-100
- Azenosertib
- (no location specified)
Oct 31, 2023
Ovarian Clear Cell Carcinoma Trial in Houston (Dostarlimab, LB-100)
Not yet recruiting
- Ovarian Clear Cell Carcinoma
- Dostarlimab
- LB-100
-
Houston, TexasM D Anderson Cancer Center
Sep 26, 2023
Astrocytoma, Grades II, III and IV, Glioblastoma Multiforme, Giant Cell Glioblastoma Trial run by the National Cancer Institute
Recruiting
- Astrocytoma, Grades II, III and IV
- +4 more
- LB-100
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 31, 2023
MDS Trial in Tampa (LB-100)
Unknown status
- Myelodysplastic Syndromes
- LB-100
-
Tampa, FloridaH. Lee Moffitt Cancer Center & Research Institute
Apr 4, 2019